Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hong Chen"'
Publikováno v:
Oncotarget
Invasive pulmonary aspergillosis (IPA) is an infection that often occurs in immunocompromised patients and has a high mortality rate. In recent years, the reported incidence of IPA in the context of chronic obstructive pulmonary disease (COPD) has se
Autor:
Feng-Cheng Liu, Ren-Yeong Huang, Chi-Tsung Wu, Chin-Sheng Lin, Kuen-Tze Lin, Yu-Hsiang Chiu, Hsiang-Cheng Chen, Chi-Hsiang Chung, Wu-Chien Chien, Jia-Hong Chen
Publikováno v:
Oncotarget
// Yu-Hsiang Chiu 1 , Chi-Hsiang Chung 2 , Kuen-Tze Lin 3 , Chin-Sheng Lin 4 , Jia-Hong Chen 5 , Hsiang-Cheng Chen 1 , Ren-Yeong Huang 6 , Chi-Tsung Wu 7 , Feng-Cheng Liu 1 and Wu-Chien Chien 2,8 1 Department of Internal Medicine, Division of Rheumat
Publikováno v:
Oncotarget
We reported that long non-coding RNA ZFAS1 was upregulated in epithelial ovarian cancer tissues, and was negatively correlated to the overall survival rate of patients with epithelial ovarian cancer in this study. While depletion of ZFAS1 inhibited p
Autor:
Qiuyi Zhang, Yi-Long Wu, Wei Deng, Jian Su, Jin-Ji Yang, Xu-Chao Zhang, Hong-Hong Yan, Zhi-Hong Chen, Ning Zhao, E-E Ke, Chong-Rui Xu, Fei-Yu Niu, Qing Zhou
Publikováno v:
Oncotarget
Epidermal growth factor receptor (EGFR) T790M mutation has shown to be associated with the clinical outcomes of patients after initial EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy in EGFR-mutant advanced non-small cell lung cancer (NSCLC). Howev
Autor:
Xi Li, Xiao-Ping Chen, Ji-Ye Yin, Xiao-Qing Yuan, Ke-Wei Zhu, Hui Zeng, Xiao-Lin Li, Dao-Yu Zhang, Yong-Long Yang, Yan-Hong Chen, Han Yan
Publikováno v:
Oncotarget
// Xiao-Qing Yuan 1, 2 , Dao-Yu Zhang 1, 2 , Han Yan 1, 2 , Yong-Long Yang 3 , Ke-Wei Zhu 1, 2 , Yan-Hong Chen 1, 2 , Xi Li 1, 2 , Ji-Ye Yin 1, 2 , Xiao-Lin Li 4 , Hui Zeng 4 , Xiao-Ping Chen 1, 2, 5 1 Department of Clinical Pharmacology, Xiangya Hos
Autor:
Jac A. Nickoloff, Wen Cheng Lo, David F. Williams, Wei Hong Chen, Ya Ting Chang, Cheng-Wen Wu, Hong-Jian Wei, Pan-Chyr Yang, Juri G. Gelovani, Win Ping Deng, Hen Yu Liu
Publikováno v:
Oncotarget
Several reports suggest that malignant cells generate phenotypic diversity through fusion with various types of stromal cells within the tumor microenvironment. Mesenchymal stem cell (MSC) is one of the critical components in the tumor microenvironme